nicotinamide arabinoside adenine dinucleotide has been researched along with cyclic adp-ribose in 1 studies
| Studies (nicotinamide arabinoside adenine dinucleotide) | Trials (nicotinamide arabinoside adenine dinucleotide) | Recent Studies (post-2010) (nicotinamide arabinoside adenine dinucleotide) | Studies (cyclic adp-ribose) | Trials (cyclic adp-ribose) | Recent Studies (post-2010) (cyclic adp-ribose) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 758 | 0 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lund, FE; Makris, M; Moreno-García, ME; Muller-Steffner, H; Oppenheimer, NJ; Partida-Sánchez, S; Romero-Ramirez, H; Santos-Argumedo, L; Schuber, F | 1 |
1 other study(ies) available for nicotinamide arabinoside adenine dinucleotide and cyclic adp-ribose
| Article | Year |
|---|---|
CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Apoptosis; B-Lymphocytes; Calcium; Calcium Signaling; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic ADP-Ribose; Enzyme Inhibitors; Hematopoietic Stem Cells; Immunologic Capping; Leukemia, B-Cell; Lymphocyte Activation; Membrane Microdomains; Mice; NAD | 2006 |